23andme - Search News

Order byBest matchMost fresh

Regeneron buying 23andMe

Top News

Overview

Impacts

Regeneron buying 23andMe; What happened to 23andMe? Should I delete 23andMe data?

California Attorney General Rob Bonta urged customers to consider directing 23andMe to delete their data and destroy their DNA.

· 4h

· 1d · on MSN

23andMe sold in bankruptcy: What it means for your DNA data

· 1d · on MSN

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million

Struggling DNA testing firm 23andMe to be bought for $256m

23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m (£192m).

· 1d

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

· 1d

Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Hold...

· 1d

Biotechnology company Regeneron buying 23andMe for $256 million

· 1d

Bankrupt DNA testing company 23andMe to be bought by Regeneron

1don MSN

Genetic data will be safeguarded with 23andMe sale, drugmaker vows

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices to protect customer data.

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.

1don MSN

Regeneron agrees to buy bankrupt 23andMe, promises ethical use of customers' DNA data

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of customers' DNA data.

1don MSN

23andMe sells gene-testing business to DNA drug maker Regeneron

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.